47 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
10 Dec 20
Financial Statements and Exhibits
4:13pm
Effective January 1, 2019, the Company adopted Accounting Standards Codification (ASC) 842, Leases (ASC 842). This standard increases transparency
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
20 Oct 20
Results of Operations and Financial Condition
10:52am
programs Governance Diverse Board of Directors; all directors, aside from CEO, independent including the Chairman; transparency with stakeholders
20 … Clinical Pharmacy Specialist UCLA Ronald Reagan Medical Center Mrdavis@mednet.ucla.edu @Mattdavis138 55
Transparency Declaration No disclosures related
8-K
EX-2.1
iops0ds4bn7ymwga
9 Aug 18
Entry into a Material Definitive Agreement
9:05am
8-K
EX-10.5
2bkz5gor z9h
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.3
t1wgv
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.4
a754jwqq9 9h6sxa
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.7
6t6jom
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.8
f9m0b
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.9
xxf92 56k5yvgyis
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.11
ehdxi8unojedw c5htet
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.2
00hmyho qsuamh
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.6
l68dl49kx
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.12
a1vfz
22 May 18
Entry into a Material Definitive Agreement
5:12pm